TreeWAS – Variant ID: rs17309930

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
K57.3 Diverticular disease of large intestine without perforation or abscess	0.000	0.000	1.000
K57 Diverticular disease of intestine	0.000	0.000	1.000
K57.9 Diverticular disease of intestine, part unspecified, without perforation or abscess	0.000	0.001	0.999
K57.2 Diverticular disease of large intestine with perforation and abscess	0.000	0.002	0.998
K57.5 Diverticular disease of both small and large intestine without perforation or abscess	0.000	0.152	0.848
K57.0 Diverticular disease of small intestine with perforation and abscess	0.000	0.245	0.755
K57.8 Diverticular disease of intestine, part unspecified, with perforation and abscess	0.000	0.258	0.742
K57.4 Diverticular disease of both small and large intestine with perforation and abscess	0.000	0.375	0.625
K57.1 Diverticular disease of small intestine without perforation or abscess	0.001	0.832	0.166
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.070	0.930	0.000
Y40 Systemic antibiotics	0.069	0.931	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.069	0.931	0.000
Y52 Agents primarily affecting the cardiovascular system	0.068	0.932	0.000
Y40.9 Systemic antibiotic, unspecified	0.065	0.935	0.000
Y46.4 Iminostilbenes	0.064	0.936	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.064	0.936	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.063	0.937	0.000
Y46.2 Hydantoin derivatives	0.062	0.938	0.000
Y40.8 Other systemic antibiotics	0.060	0.940	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.059	0.941	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.059	0.941	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.057	0.943	0.000
N20 Calculus of kidney and ureter	0.000	0.943	0.057
N20.1 Calculus of ureter	0.000	0.943	0.057
Y44 Agents primarily affecting blood constituents	0.056	0.944	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.056	0.944	0.000
N20.0 Calculus of kidney	0.000	0.944	0.056
Y40.0 Penicillins	0.056	0.944	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.055	0.945	0.000
Y40.6 Rifamycins	0.054	0.946	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.052	0.948	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.052	0.948	0.000
Y46.6 Other and unspecified antiepileptics	0.051	0.948	0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.051	0.949	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.051	0.949	0.000
Y40.5 Aminoglycosides	0.051	0.949	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.050	0.949	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.050	0.949	0.000
Y58 Bacterial vaccines	0.050	0.950	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.050	0.950	0.000
Y59 Other and unspecified vaccines and biological substances	0.050	0.950	0.000
Y40.7 Antifungal antibiotics, systemically used	0.050	0.950	0.000
Y40.4 Tetracyclines	0.050	0.950	0.000
Y40.2 Chloramphenicol group	0.050	0.950	0.000
Y46.8 Antispasticity drugs	0.050	0.950	0.000
Y46.7 Anti-Parkinsonism drugs	0.050	0.950	0.000
Y46.5 Valproic acid	0.050	0.950	0.000
Y46.3 Deoxybarbiturates	0.050	0.950	0.000
Y46.1 Oxazolidinediones	0.050	0.950	0.000
Y46.0 Succinimides	0.050	0.950	0.000
N20.2 Calculus of kidney with calculus of ureter	0.000	0.950	0.050
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.049	0.951	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.049	0.951	0.000
Y52.7 Peripheral vasodilators	0.049	0.951	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.049	0.951	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.049	0.951	0.000
N20.9 Urinary calculus, unspecified	0.000	0.951	0.049
Y49 Psychotropic drugs, not elsewhere classified	0.049	0.951	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.048	0.951	0.000
Y48 Anaesthetics and therapeutic gases	0.048	0.952	0.000
Y40.3 Macrolides	0.048	0.952	0.000
Y52.1 Calcium-channel blockers	0.047	0.953	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.047	0.953	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.047	0.953	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.046	0.953	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.046	0.954	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.046	0.954	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.046	0.954	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.046	0.954	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.046	0.954	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.046	0.954	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.046	0.954	0.000
Y51.0 Anticholinesterase agents	0.046	0.954	0.000
Y44.5 Thrombolytic drugs	0.045	0.955	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.044	0.956	0.000
Y47.1 Benzodiazepines	0.044	0.956	0.000
Y40.1 Cefalosporins and other -lactam antibiotics	0.043	0.957	0.000
Y45.0 Opioids and related analgesics	0.043	0.957	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.042	0.957	0.000
Y56.9 Topical agent, unspecified	0.042	0.957	0.000
Y56.8 Other topical agents	0.042	0.957	0.000
Y56.7 Dental drugs, topically applied	0.042	0.957	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.042	0.957	0.000
Y56.5 Ophthalmological drugs and preparations	0.042	0.957	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.042	0.957	0.000
Y56.3 Emollients, demulcents and protectants	0.042	0.957	0.000
Y56.2 Local astringents and local detergents	0.042	0.957	0.000
Y56.1 Antipruritics	0.042	0.957	0.000
Y45.2 Propionic acid derivatives	0.042	0.958	0.000
Y45.1 Salicylates	0.041	0.959	0.000
Y54.8 Agents affecting uric acid metabolism	0.041	0.959	0.000
Y42.9 Other and unspecified hormone antagonists	0.041	0.959	0.000
Y54.5 Other diuretics	0.041	0.959	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.040	0.959	0.000
Y44.7 Plasma substitutes	0.040	0.959	0.000
Y44.6 Natural blood and blood products	0.040	0.959	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.040	0.959	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.040	0.959	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.040	0.959	0.000
Y55.5 Anticommon cold drugs	0.040	0.959	0.000
Y55.4 Expectorants	0.040	0.959	0.000
Y55.3 Antitussives	0.040	0.959	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.040	0.959	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.040	0.959	0.000
Y55.0 Oxytocic drugs	0.040	0.959	0.000
Y42.2 Antithyroid drugs	0.040	0.960	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.039	0.960	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.039	0.960	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.039	0.960	0.000
Y47.4 Bromine compounds	0.039	0.960	0.000
Y47.3 Paraldehyde	0.039	0.960	0.000
Y47.2 Chloral derivatives	0.039	0.960	0.000
Y47.0 Barbiturates, not elsewhere classified	0.039	0.960	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.039	0.961	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.039	0.961	0.000
Y45.5 4-Aminophenol derivatives	0.039	0.961	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.038	0.962	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.038	0.962	0.000
Y42.5 Other oestrogens and progestogens	0.038	0.962	0.000
Y48.2 Other and unspecified general anaesthetics	0.038	0.962	0.000
Y54.9 Mineral salts, not elsewhere classified	0.038	0.962	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.038	0.962	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.038	0.962	0.000
Y54.0 Mineralocorticoids	0.038	0.962	0.000
Y45.4 Antirheumatics	0.037	0.962	0.000
Y54.7 Agents affecting calcification	0.037	0.963	0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.037	0.963	0.000
Y50.9 Central nervous system stimulant, unspecified	0.036	0.963	0.000
Y50.8 Other central nervous system stimulants	0.036	0.963	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.036	0.963	0.000
Y50.1 Opioid receptor antagonists	0.036	0.963	0.000
Y50.0 Analeptics	0.036	0.963	0.000
Y58.9 Other and unspecified bacterial vaccines	0.036	0.964	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.036	0.964	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.036	0.964	0.000
Y58.5 Diphtheria vaccine	0.036	0.964	0.000
Y58.4 Tetanus vaccine	0.036	0.964	0.000
Y58.3 Plague vaccine	0.036	0.964	0.000
Y58.2 Cholera vaccine	0.036	0.964	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.036	0.964	0.000
Y58.0 BCG vaccine	0.036	0.964	0.000
Y59.9 Vaccine or biological substance, unspecified	0.036	0.964	0.000
Y59.8 Other specified vaccines and biological substances	0.036	0.964	0.000
Y59.2 Protozoal vaccines	0.036	0.964	0.000
Y59.1 Rickettsial vaccines	0.036	0.964	0.000
Y59.0 Viral vaccines	0.036	0.964	0.000
Y41.1 Antimycobacterial drugs	0.036	0.964	0.000
Y59.3 Immunoglobulin	0.035	0.964	0.000
Y42.4 Oral contraceptives	0.035	0.965	0.000
Y42.1 Thyroid hormones and substitutes	0.035	0.965	0.000
Y49.9 Psychotropic drug, unspecified	0.035	0.965	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.035	0.965	0.000
Y49.7 Psychostimulants with abuse potential	0.035	0.965	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.035	0.965	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.035	0.965	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.035	0.965	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.035	0.965	0.000
Y41.4 Anthelminthics	0.035	0.965	0.000
Y41.3 Other antiprotozoal drugs	0.035	0.965	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.035	0.965	0.000
Y45.8 Other analgesics and antipyretics	0.035	0.965	0.000
Y48.3 Local anaesthetics	0.035	0.965	0.000
Y48.5 Therapeutic gases	0.035	0.965	0.000
Y48.1 Parenteral anaesthetics	0.035	0.965	0.000
Y48.0 Inhaled anaesthetics	0.035	0.965	0.000
Y54.3 Benzothiadiazine derivatives	0.035	0.965	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.034	0.965	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.034	0.966	0.000
Y54.4 Loop [high-ceiling] diuretics	0.034	0.966	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.033	0.966	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.033	0.966	0.000
Y53.7 Emetics	0.033	0.966	0.000
Y53.6 Antidiarrhoeal drugs	0.033	0.966	0.000
Y53.5 Digestants	0.033	0.966	0.000
Y53.3 Saline and osmotic laxatives	0.033	0.966	0.000
Y53.2 Stimulant laxatives	0.033	0.966	0.000
Y53.0 Histamine H2-receptor antagonists	0.033	0.966	0.000
Y41.0 Sulphonamides	0.033	0.967	0.000
Y41.5 Antiviral drugs	0.032	0.968	0.000
Y49.5 Other antipsychotics and neuroleptics	0.031	0.969	0.000
Y42.0 Glucocorticoids and synthetic analogs	0.030	0.969	0.000
Y44.2 Anticoagulants	0.029	0.971	0.000
Y53.4 Other laxatives	0.029	0.971	0.000
Y48.4 Anaesthetic, unspecified	0.028	0.971	0.000
Y49.2 Other and unspecified antidepressants	0.028	0.972	0.000
Y42.7 Androgens and anabolic congeners	0.028	0.972	0.000
D86.9 Sarcoidosis, unspecified	0.028	0.972	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.027	0.973	0.000
D86 Sarcoidosis	0.027	0.973	0.000
Y57 Other and unspecified drugs and medicaments	0.026	0.974	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.026	0.974	0.000
D86.0 Sarcoidosis of lung	0.024	0.976	0.000
D86.8 Sarcoidosis of other and combined sites	0.023	0.977	0.000
O99.0 Anaemia complicating pregnancy, childbirth and the puerperium	0.000	0.978	0.022
Y43 Primarily systemic agents	0.021	0.979	0.000
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes	0.020	0.980	0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.020	0.980	0.000
D86.3 Sarcoidosis of skin	0.020	0.980	0.000
N20-N23 Urolithiasis	0.000	0.980	0.020
D80-D89 Certain disorders involving the immune mechanism	0.020	0.980	0.000
Y57.7 Vitamins, not elsewhere classified	0.019	0.981	0.000
Y57.4 Pharmaceutical excipients	0.019	0.981	0.000
Y57.3 Alcohol deterrents	0.019	0.981	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.019	0.981	0.000
Y57.1 Lipotropic drugs	0.019	0.981	0.000
Y57.0 Appetite depressants [anorectics]	0.019	0.981	0.000
Y57.8 Other drugs and medicaments	0.019	0.981	0.000
D86.1 Sarcoidosis of lymph nodes	0.018	0.981	0.000
O99 Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium	0.000	0.983	0.017
D84 Other immunodeficiencies	0.016	0.983	0.000
N21 Calculus of lower urinary tract	0.000	0.984	0.016
D89 Other disorders involving the immune mechanism, not elsewhere classified	0.015	0.984	0.000
Y57.5 X-ray contrast media	0.015	0.985	0.000
D82 Immunodeficiency associated with other major defects	0.015	0.985	0.000
O99.8 Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium	0.000	0.985	0.015
Y43.9 Primarily systemic agent, unspecified	0.015	0.985	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.015	0.985	0.000
Y43.6 Enzymes, not elsewhere classified	0.015	0.985	0.000
Y43.5 Acidifying and alkalising agents	0.015	0.985	0.000
Y43.2 Antineoplastic natural products	0.015	0.985	0.000
D80 Immunodeficiency with predominantly antibody defects	0.015	0.985	0.000
Y43.1 Antineoplastic antimetabolites	0.015	0.985	0.000
Y57.6 Other diagnostic agents	0.014	0.985	0.000
D83 Common variable immunodeficiency	0.014	0.985	0.000
D84.9 Immunodeficiency, unspecified	0.014	0.986	0.000
Y57.9 Drug or medicament, unspecified	0.014	0.986	0.000
N22 Calculus of urinary tract in diseases classified elsewhere	0.000	0.986	0.014
D81 Combined immunodeficiencies	0.014	0.986	0.000
Y43.4 Immunosuppressive agents	0.014	0.986	0.000
O32.1 Maternal care for breech presentation	0.000	0.986	0.014
O32 Maternal care for known or suspected malpresentation of foetus	0.000	0.986	0.014
O99.6 Diseases of the digestive system complicating pregnancy, childbirth and the puerperium	0.000	0.986	0.013
O99.3 Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium	0.000	0.986	0.013
O99.4 Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium	0.000	0.987	0.013
N21.1 Calculus in urethra	0.000	0.987	0.013
O99.5 Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium	0.000	0.987	0.013
D89.2 Hypergammaglobulinaemia, unspecified	0.013	0.987	0.000
G91.9 Hydrocephalus, unspecified	0.000	0.987	0.013
O82.1 Delivery by emergency Caesarean section	0.000	0.987	0.013
O32.0 Maternal care for unstable lie	0.000	0.987	0.013
Y43.0 Antiallergic and antiemetic drugs	0.013	0.987	0.000
O82 Single delivery by Caesarean section	0.000	0.987	0.013
O82.0 Delivery by elective Caesarean section	0.000	0.987	0.013
O99.7 Diseases of the skin and subcutaneous tissue complicating pregnancy, childbirth and the puerperium	0.000	0.987	0.012
D80.9 Immunodeficiency with predominantly antibody defects, unspecified	0.012	0.987	0.000
O32.5 Maternal care for multiple gestation with malpresentation of one foetus or more	0.000	0.987	0.012
D82.1 Di George's syndrome	0.012	0.988	0.000
N21.8 Other lower urinary tract calculus	0.000	0.988	0.012
N21.0 Calculus in bladder	0.000	0.988	0.012
G91 Hydrocephalus	0.000	0.988	0.012
D84.8 Other specified immunodeficiencies	0.012	0.988	0.000
D84.1 Defects in the complement system	0.012	0.988	0.000
D84.0 Lymphocyte function antigen-1 [LFA-1] defect	0.012	0.988	0.000
N21.9 Calculus of lower urinary tract, unspecified	0.000	0.988	0.012
G91.1 Obstructive hydrocephalus	0.000	0.988	0.012
D89.1 Cryoglobulinaemia	0.012	0.988	0.000
O46.9 Antepartum haemorrhage, unspecified	0.000	0.988	0.012
O32.2 Maternal care for transverse and oblique lie	0.000	0.988	0.011
D89.8 Other specified disorders involving the immune mechanism, not elsewhere classified	0.011	0.989	0.000
D89.3 Immune reconstitution syndrome	0.011	0.989	0.000
D89.0 Polyclonal hypergammaglobulinaemia	0.011	0.989	0.000
D82.9 Immunodeficiency associated with major defect, unspecified	0.011	0.989	0.000
D82.8 Immunodeficiency associated with other specified major defects	0.011	0.989	0.000
D82.4 Hyperimmunoglobulin E [IgE] syndrome	0.011	0.989	0.000
D82.3 Immunodeficiency following hereditary defective response to Epstein-Barr virus	0.011	0.989	0.000
D82.2 Immunodeficiency with short-limbed stature	0.011	0.989	0.000
D82.0 Wiskott-Aldrich syndrome	0.011	0.989	0.000
O32.9 Maternal care for malpresentation of foetus, unspecified	0.000	0.989	0.011
O99.1 Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium	0.000	0.989	0.011
O99.2 Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium	0.000	0.989	0.011
G95 Other diseases of spinal cord	0.000	0.989	0.011
D80.8 Other immunodeficiencies with predominantly antibody defects	0.011	0.989	0.000
D80.7 Transient hypogammaglobulinaemia of infancy	0.011	0.989	0.000
D80.6 Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia	0.011	0.989	0.000
D80.5 Immunodeficiency with increased immunoglobulin M [IgM]	0.011	0.989	0.000
D80.4 Selective deficiency of immunoglobulin M [IgM]	0.011	0.989	0.000
D80.3 Selective deficiency of immunoglobulin G [IgG] subclasses	0.011	0.989	0.000
D80.0 Hereditary hypogammaglobulinaemia	0.011	0.989	0.000
D83.9 Common variable immunodeficiency, unspecified	0.011	0.989	0.000
O94-O99 Other obstetric conditions, not elsewhere classified	0.000	0.989	0.011
O62.2 Other uterine inertia	0.000	0.989	0.011
D80.1 Nonfamilial hypogammaglobulinaemia	0.011	0.989	0.000
D22.3 Melanocytic naevi of other and unspecified parts of face	0.000	0.989	0.011
G95.8 Other specified diseases of spinal cord	0.000	0.989	0.011
D83.8 Other common variable immunodeficiencies	0.010	0.989	0.000
D83.2 Common variable immunodeficiency with autoantibodies to B- or T-cells	0.010	0.989	0.000
D83.1 Common variable immunodeficiency with predominant immunoregulatory T-cell disorders	0.010	0.989	0.000
D83.0 Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function	0.010	0.989	0.000
O82.9 Delivery by Caesarean section, unspecified	0.000	0.989	0.011
N22.8 Calculus of urinary tract in other diseases classified elsewhere	0.000	0.989	0.010
N22.0 Calculus of urinary tract in schistosomiasis [bilharziasis]	0.000	0.989	0.010
D81.9 Combined immunodeficiency, unspecified	0.010	0.990	0.000
D81.8 Other combined immunodeficiencies	0.010	0.990	0.000
D81.7 Major histocompatibility complex class II deficiency	0.010	0.990	0.000
D81.6 Major histocompatibility complex class I deficiency	0.010	0.990	0.000
D81.5 Purine nucleoside phosphorylase [PNP] deficiency	0.010	0.990	0.000
D81.4 Nezelof's syndrome	0.010	0.990	0.000
D81.3 Adenosine deaminase [ADA] deficiency	0.010	0.990	0.000
D81.2 Severe combined immunodeficiency [SCID] with low or normal B-cell numbers	0.010	0.990	0.000
D81.1 Severe combined immunodeficiency [SCID] with low T- and B-cell numbers	0.010	0.990	0.000
D81.0 Severe combined immunodeficiency [SCID] with reticular dysgenesis	0.010	0.990	0.000
I87.2 Venous insufficiency (chronic) (peripheral)	0.010	0.990	0.000
O32.8 Maternal care for other malpresentation of foetus	0.000	0.990	0.010
O32.3 Maternal care for face, brow and chin presentation	0.000	0.990	0.010
O32.6 Maternal care for compound presentation	0.000	0.990	0.010
G95.2 Cord compression, unspecified	0.000	0.990	0.010
D80.2 Selective deficiency of immunoglobulin A [IgA]	0.010	0.990	0.000
D89.9 Disorder involving the immune mechanism, unspecified	0.010	0.990	0.000
G90-G99 Other disorders of the nervous system	0.000	0.990	0.010
O62 Abnormalities of forces of labour	0.000	0.990	0.010
O82.8 Other single delivery by Caesarean section	0.000	0.991	0.009
O82.2 Delivery by Caesarean hysterectomy	0.000	0.991	0.009
G95.1 Vascular myelopathies	0.000	0.991	0.009
O80-O84 Delivery	0.000	0.991	0.009
O46 Antepartum haemorrhage, not elsewhere classified	0.000	0.991	0.009
O62.1 Secondary uterine inertia	0.000	0.991	0.009
G91.3 Posttraumatic hydrocephalus, unspecified	0.000	0.991	0.009
G91.2 Normal-pressure hydrocephalus	0.000	0.991	0.009
O62.0 Primary inadequate contractions	0.000	0.991	0.009
G95.0 Syringomyelia and syringobulbia	0.000	0.991	0.009
G98 Other disorders of nervous system, not elsewhere classified	0.000	0.991	0.009
G91.8 Other hydrocephalus	0.000	0.991	0.008
O32.4 Maternal care for high head at term	0.000	0.991	0.008
G91.0 Communicating hydrocephalus	0.000	0.992	0.008
S02.60 Fracture of mandible (closed)	0.008	0.992	0.000
O97 Death from sequelae of direct obstetric causes	0.000	0.992	0.008
O96 Death from any obstetric cause occurring more than 42 days but less than one year after delivery	0.000	0.992	0.008
O95 Obstetric death of unspecified cause	0.000	0.992	0.008
O94 Sequelae of complication of pregnancy, childbirth and the puerperium	0.000	0.992	0.008
N23 Unspecified renal colic	0.000	0.992	0.008
O98 Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium	0.000	0.992	0.007
G94 Other disorders of brain in diseases classified elsewhere	0.000	0.993	0.007
G92 Toxic encephalopathy	0.000	0.993	0.007
O62.9 Abnormality of forces of labour, unspecified	0.000	0.993	0.007
O62.8 Other abnormalities of forces of labour	0.000	0.993	0.007
K58.0 Irritable bowel syndrome with diarrhoea	0.007	0.993	0.000
O68.8 Labour and delivery complicated by other evidence of foetal stress	0.000	0.993	0.007
O30-O48 Maternal care related to the fetus and amniotic cavity and possible delivery problems	0.000	0.993	0.007
Chapter XV Pregnancy, childbirth and the puerperium	0.000	0.993	0.007
O81 Single delivery by forceps and vacuum extractor	0.000	0.993	0.007
G99 Other disorders of nervous system in diseases classified elsewhere	0.000	0.993	0.007
O84 Multiple delivery	0.000	0.993	0.007
O83 Other assisted single delivery	0.000	0.993	0.007
O46.8 Other antepartum haemorrhage	0.000	0.993	0.007
O46.0 Antepartum haemorrhage with coagulation defect	0.000	0.993	0.007
G96 Other disorders of central nervous system	0.000	0.993	0.007
O62.4 Hypertonic, incoordinate and prolonged uterine contractions	0.000	0.993	0.007
G95.9 Disease of spinal cord, unspecified	0.000	0.993	0.007
O80 Single spontaneous delivery	0.000	0.993	0.007
O35 Maternal care for known or suspected foetal abnormality and damage	0.000	0.993	0.006
O68 Labour and delivery complicated by foetal stress [distress]	0.000	0.994	0.006
G93.8 Other specified disorders of brain	0.000	0.994	0.006
O47 False labour	0.000	0.994	0.006
O80.0 Spontaneous vertex delivery	0.000	0.994	0.006
G93 Other disorders of brain	0.000	0.994	0.006
O96.9 Death from unspecified obstetric cause	0.000	0.994	0.006
O96.1 Death from indirect obstetric cause	0.000	0.994	0.006
O96.0 Death from direct obstetric cause	0.000	0.994	0.006
O97.9 Death from sequelae of obstetric cause, unspecified	0.000	0.994	0.006
O97.1 Death from sequelae of indirect obstetric cause	0.000	0.994	0.006
O97.0 Death from sequelae of direct obstetric cause	0.000	0.994	0.006
O68.9 Labour and delivery complicated by foetal stress, unspecified	0.000	0.994	0.006
O60-O75 Complications of labour and delivery	0.000	0.994	0.006
G96.1 Disorders of meninges, not elsewhere classified	0.000	0.994	0.006
O35.9 Maternal care for (suspected) foetal abnormality and damage, unspecified	0.000	0.994	0.006
O47.9 False labour, unspecified	0.000	0.994	0.006
D22.4 Melanocytic naevi of scalp and neck	0.000	0.994	0.006
Z99.2 Dependence on renal dialysis	0.006	0.994	0.000
G90 Disorders of autonomic nervous system	0.000	0.994	0.006
G94.1 Hydrocephalus in neoplastic disease	0.000	0.994	0.006
G97 Postprocedural disorders of nervous system, not elsewhere classified	0.000	0.994	0.006
H54.9 Unspecified visual impairment (binocular)	0.006	0.994	0.000
I87 Other disorders of veins	0.006	0.994	0.000
O45 Premature separation of placenta [abruptio placentae]	0.000	0.994	0.006
O81.4 Vacuum extractor delivery	0.000	0.994	0.006
O98.9 Unspecified maternal infectious or parasitic disease complicating pregnancy, childbirth and the puerperium	0.000	0.994	0.005
O98.7 Human immunodeficiency [HIV] disease complicating pregnancy, childbirth and the puerperium	0.000	0.994	0.005
O98.6 Protozoal diseases complicating pregnancy, childbirth and the puerperium	0.000	0.994	0.005
O98.4 Viral hepatitis complicating pregnancy, childbirth and the puerperium	0.000	0.994	0.005
O98.3 Other infections with a predominantly sexual mode of transmission complicating pregnancy, childbirth and the puerperium	0.000	0.994	0.005
O98.2 Gonorrhoea complicating pregnancy, childbirth and the puerperium	0.000	0.994	0.005
O98.1 Syphilis complicating pregnancy, childbirth and the puerperium	0.000	0.994	0.005
O98.0 Tuberculosis complicating pregnancy, childbirth and the puerperium	0.000	0.994	0.005
G94.8 Other specified disorders of brain in diseases classified elsewhere	0.000	0.994	0.005
G94.0 Hydrocephalus in infectious and parasitic diseases classified elsewhere	0.000	0.994	0.005
D22 Melanocytic naevi	0.000	0.994	0.006
O98.8 Other maternal infectious and parasitic diseases complicating pregnancy, childbirth and the puerperium	0.000	0.994	0.005
O81.3 Other and unspecified forceps delivery	0.000	0.994	0.005
O68.2 Labour and delivery complicated by foetal heart rate anomaly with meconium in amniotic fluid	0.000	0.994	0.005
G94.2 Hydrocephalus in other diseases classified elsewhere	0.000	0.995	0.005
O75 Other complications of labour and delivery, not elsewhere classified	0.000	0.995	0.005
E11.9 Without complications	0.005	0.995	0.000
O35.8 Maternal care for other (suspected) foetal abnormality and damage	0.000	0.995	0.005
O62.3 Precipitate labour	0.000	0.995	0.005
S02.6 Fracture of mandible	0.005	0.995	0.000
Z09.9 Follow-up examination after unspecified treatment for other conditions	0.000	0.995	0.005
O40 Polyhydramnios	0.000	0.995	0.005
Z09.8 Follow-up examination after other treatment for other conditions	0.000	0.995	0.005
O81.5 Delivery by combination of forceps and vacuum extractor	0.000	0.995	0.005
O81.2 Mid-cavity forceps with rotation	0.000	0.995	0.005
O81.1 Mid-cavity forceps delivery	0.000	0.995	0.005
G99.8 Other specified disorders of nervous system in diseases classified elsewhere	0.000	0.995	0.005
G99.2 Myelopathy in diseases classified elsewhere	0.000	0.995	0.005
G99.1 Other disorders of autonomic nervous system in other diseases classified elsewhere	0.000	0.995	0.005
O83.9 Assisted single delivery, unspecified	0.000	0.995	0.005
O83.8 Other specified assisted single delivery	0.000	0.995	0.005
O83.4 Destructive operation for delivery	0.000	0.995	0.005
O83.3 Delivery of viable foetus in abdominal pregnancy	0.000	0.995	0.005
O83.2 Other manipulation-assisted delivery	0.000	0.995	0.005
O83.1 Other assisted breech delivery	0.000	0.995	0.005
O83.0 Breech extraction	0.000	0.995	0.005
O84.9 Multiple delivery, unspecified	0.000	0.995	0.005
O84.8 Other multiple delivery	0.000	0.995	0.005
O84.2 Multiple delivery, all by Caesarean section	0.000	0.995	0.005
O84.1 Multiple delivery, all by forceps and vacuum extractor	0.000	0.995	0.005
O84.0 Multiple delivery, all spontaneous	0.000	0.995	0.005
G90.9 Disorder of autonomic nervous system, unspecified	0.000	0.995	0.005
I87.8 Other specified disorders of veins	0.005	0.995	0.000
O72 Postpartum haemorrhage	0.000	0.995	0.005
G96.9 Disorder of central nervous system, unspecified	0.000	0.995	0.005
G96.8 Other specified disorders of central nervous system	0.000	0.995	0.005
N13.4 Hydroureter	0.000	0.995	0.005
N13.2 Hydronephrosis with renal and ureteral calculous obstruction	0.000	0.995	0.005
O98.5 Other viral diseases complicating pregnancy, childbirth and the puerperium	0.000	0.995	0.005
N13 Obstructive and reflux uropathy	0.000	0.995	0.005
Z09 Follow-up examination after treatment for conditions other than malignant neoplasms	0.000	0.995	0.005
D41.4 Bladder	0.005	0.995	0.000
G93.2 Benign intracranial hypertension	0.000	0.995	0.005
N13.9 Obstructive and reflux uropathy, unspecified	0.000	0.995	0.005
O75.0 Maternal distress during labour and delivery	0.000	0.995	0.005
N13.8 Other obstructive and reflux uropathy	0.000	0.995	0.005
O80.1 Spontaneous breech delivery	0.000	0.995	0.005
O35.7 Maternal care for (suspected) damage to foetus by other medical procedures	0.000	0.995	0.005
O35.6 Maternal care for (suspected) damage to foetus by radiation	0.000	0.995	0.005
O35.5 Maternal care for (suspected) damage to foetus by drugs	0.000	0.995	0.005
O35.4 Maternal care for (suspected) damage to foetus from alcohol	0.000	0.995	0.005
O35.3 Maternal care for (suspected) damage to foetus from viral disease in mother	0.000	0.995	0.005
O35.2 Maternal care for (suspected) hereditary disease in foetus	0.000	0.995	0.005
O35.0 Maternal care for (suspected) central nervous system malformation in foetus	0.000	0.995	0.005
O68.3 Labour and delivery complicated by biochemical evidence of foetal stress	0.000	0.995	0.005
Z09.0 Follow-up examination after surgery for other conditions	0.000	0.995	0.005
S02.40 Fracture of malar and maxillary bones (closed)	0.005	0.995	0.000
G99.0 Autonomic neuropathy in endocrine and metabolic diseases	0.000	0.995	0.005
D22.2 Melanocytic naevi of ear and external auricular canal	0.000	0.995	0.005
G93.4 Encephalopathy, unspecified	0.000	0.995	0.005
O47.1 False labour at or after 37 completed weeks of gestation	0.000	0.995	0.005
O72.2 Delayed and secondary postpartum haemorrhage	0.000	0.995	0.005
E11.2 With renal complications	0.005	0.995	0.000
O45.9 Premature separation of placenta, unspecified	0.000	0.995	0.005
G93.7 Reye's syndrome	0.000	0.995	0.005
G93.5 Compression of brain	0.000	0.995	0.005
O47.0 False labour before 37 completed weeks of gestation	0.000	0.995	0.005
O75.2 Pyrexia during labour, not elsewhere classified	0.000	0.995	0.005
H54.7 Unspecified visual loss	0.005	0.995	0.000
M51.9 Intervertebral disk disorder, unspecified	0.005	0.995	0.000
O72.0 Third-stage haemorrhage	0.000	0.995	0.005
O74 Complications of anaesthesia during labour and delivery	0.000	0.995	0.005
N13.1 Hydronephrosis with ureteral stricture, not elsewhere classified	0.000	0.995	0.005
O35.1 Maternal care for (suspected) chromosomal abnormality in foetus	0.000	0.995	0.005
D22.1 Melanocytic naevi of eyelid, including canthus	0.000	0.995	0.005
O41 Other disorders of amniotic fluid and membranes	0.000	0.995	0.005
O60 Preterm delivery	0.000	0.995	0.005
O71 Other obstetric trauma	0.000	0.995	0.005
H54 Blindness and low vision	0.005	0.995	0.000
O81.0 Low forceps delivery	0.000	0.995	0.004
O31 Complications specific to multiple gestation	0.000	0.995	0.004
O75.7 Vaginal delivery following previous Caesarean section	0.000	0.995	0.005
G90.8 Other disorders of autonomic nervous system	0.000	0.995	0.004
G90.4 Autonomic dysreflexia	0.000	0.995	0.004
G90.1 Familial dysautonomia [Riley-Day]	0.000	0.995	0.004
O85-O92 Complications predominantly related to the puerperium	0.000	0.995	0.004
G93.6 Cerebral oedema	0.000	0.995	0.004
G97.9 Postprocedural disorder of nervous system, unspecified	0.000	0.995	0.004
G97.2 Intracranial hypotension following ventricular shunting	0.000	0.995	0.004
G90.2 Horner's syndrome	0.000	0.996	0.004
G93.1 Anoxic brain damage, not elsewhere classified	0.000	0.996	0.004
G97.8 Other postprocedural disorders of nervous system	0.000	0.996	0.004
I87.9 Disorder of vein, unspecified	0.004	0.996	0.000
I87.0 Postphlebitic syndrome	0.004	0.996	0.000
O33 Maternal care for known or suspected disproportion	0.000	0.996	0.004
N18.4 Chronic kidney disease, stage 4	0.004	0.996	0.000
O45.8 Other premature separation of placenta	0.000	0.996	0.004
O45.0 Premature separation of placenta with coagulation defect	0.000	0.996	0.004
O80.8 Other single spontaneous delivery	0.000	0.996	0.004
O65 Obstructed labour due to maternal pelvic abnormality	0.000	0.996	0.004
G93.0 Cerebral cysts	0.000	0.996	0.004
O75.9 Complication of labour and delivery, unspecified	0.000	0.996	0.004
O75.5 Delayed delivery after artificial rupture of membranes	0.000	0.996	0.004
O75.4 Other complications of obstetric surgery and procedures	0.000	0.996	0.004
O75.3 Other infection during labour	0.000	0.996	0.004
O75.1 Shock during or following labour and delivery	0.000	0.996	0.004
S02.61 Fracture of mandible (open)	0.004	0.996	0.000
Z09.4 Follow-up examination after treatment of fracture	0.000	0.996	0.004
O44 Placenta praevia	0.000	0.996	0.004
Z09.1 Follow-up examination after radiotherapy for other conditions	0.000	0.996	0.004
D22.9 Melanocytic naevi, unspecified	0.000	0.996	0.004
G97.0 Cerebrospinal fluid leak from spinal puncture	0.000	0.996	0.004
O75.8 Other specified complications of labour and delivery	0.000	0.996	0.004
I87.1 Compression of vein	0.004	0.996	0.000
E11 Non-insulin-dependent diabetes mellitus	0.004	0.996	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations